Skip to content

Bluejay Diagnostics, Inc.: 10-Q filed 2021-12-16

What Bluejay Diagnostics, Inc. reported in its quarterly report filed 2021-12-16 (fiscal Q3 2021): 28 published measures, 79 facts as tagged in accession 0001213900-21-065592.

This filing

Form
10-Q (quarterly report)
Filed
2021-12-16
Fiscal period
fiscal Q3 2021
Accession
0001213900-21-065592 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Bluejay Diagnostics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-303,622,698USD
At 2020-12-311,517,332USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-304,703,620USD
At 2020-12-311,845,390USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-30-1,080,922USD
At 2021-06-30-123,485USD
At 2021-03-31-4,296,576USD
At 2020-12-31-4,206,173USD
At 2020-09-30-3,741,847USD
At 2020-06-30-3,553,591USD
At 2020-03-31-3,308,121USD
At 2019-12-31-2,932,438USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-302,330,138USD
At 2020-12-31912,361USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,193,381USD92
2021-01-01 to 2021-09-30-2,027,802USD273
2020-07-01 to 2020-09-30-127,988USD92
2020-01-01 to 2020-09-30-614,260USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-1,843,722USD273
2020-01-01 to 2020-09-30-353,854USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-306,214USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-303,267,713USD273
2020-01-01 to 2020-09-30330,611USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-6,234,290USD
At 2020-12-31-4,206,488USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-30358,845USD
At 2020-12-31459,138USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-07-01 to 2021-09-3046,505USD92
2021-01-01 to 2021-09-3046,824USD273
2021-04-01 to 2021-06-30155USD91
2021-01-01 to 2021-03-31164USD90
2020-07-01 to 2020-09-306,251USD92
2020-01-01 to 2020-09-304,410USD274
2020-04-01 to 2020-06-30679USD91
2020-01-01 to 2020-03-31-2,520USD91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-957,988USD92
2021-01-01 to 2021-09-30-1,857,258USD273
2020-07-01 to 2020-09-30-148,169USD92
2020-01-01 to 2020-09-30-614,612USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-303,263,853USD
At 2020-12-311,058,194USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-3083,752USD273

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30242,856USD
At 2020-12-31374,928USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-30957,988USD92
2021-01-01 to 2021-09-301,857,258USD273
2020-07-01 to 2020-09-30148,169USD92
2020-01-01 to 2020-09-30614,612USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-12-3184,762USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-30442,527USD92
2021-01-01 to 2021-09-30692,702USD273
2020-07-01 to 2020-09-302,723USD92
2020-01-01 to 2020-09-30108,192USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3010,534,265shares
At 2020-12-313,147,200shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-305,152,314USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-30371,288USD
At 2020-12-31133,820USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-30451,407USD
At 2020-12-3161,071USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,193,381USD92
2021-04-01 to 2021-06-30-640,235USD91
2021-01-01 to 2021-03-31-194,186USD90
2020-07-01 to 2020-09-30-127,988USD92
2020-04-01 to 2020-06-30-179,628USD91
2020-01-01 to 2020-03-31-306,644USD91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30445,050USD92
2021-01-01 to 2021-09-30974,791USD273
2020-07-01 to 2020-09-30131,094USD92
2020-01-01 to 2020-09-30452,846USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-235,393USD92
2021-01-01 to 2021-09-30-170,544USD273
2020-07-01 to 2020-09-3020,181USD92
2020-01-01 to 2020-09-30352USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-3038,961USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-645USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-84,762USD273
2020-01-01 to 2020-09-3084,762USD274

Inspect the source

Entity
Bluejay Diagnostics, Inc. / CIK 0001704287
Captured
2026-09-21T17:24:11.325Z
SEC response SHA-256
7b576f6ad0703490f74bfda11e23abf7bf7547bf44a012503e93b7ff7bb8b6a6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001704287.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))